Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

SARS-CoV-2 Shielding Effect of Chitosan Derivatives: An in-silico Prospective

Version 1 : Received: 3 June 2022 / Approved: 7 June 2022 / Online: 7 June 2022 (09:05:16 CEST)

How to cite: Das, P.; Sahoo, S.; Majhi, S.; Kerry, G.R.; Jena, A.B. SARS-CoV-2 Shielding Effect of Chitosan Derivatives: An in-silico Prospective. Preprints 2022, 2022060099. https://doi.org/10.20944/preprints202206.0099.v1 Das, P.; Sahoo, S.; Majhi, S.; Kerry, G.R.; Jena, A.B. SARS-CoV-2 Shielding Effect of Chitosan Derivatives: An in-silico Prospective. Preprints 2022, 2022060099. https://doi.org/10.20944/preprints202206.0099.v1

Abstract

Abstract The present work was designed to investigate antiviral potential of novel mono and oligomeric Chitosan derivatives through in-silico approaches to find potent broad-spectrum anti-viral and promising drug candidates against SARS-CoV-2 and augmentation of their mode of action. Chitosan biopolymer and its derivatives were screened virtually against spike glycoprotein and human ACE2 receptor of nCoV-19. HTCC a polymeric Chitosan has been reported to interact with the corona viral Spike (S) protein and blocks its interaction with ACE2 receptor. Better biocompatibility, structural correlations, variation in degree of decetylation and molecular weight of modified Chitosan derivatives are the key attributes for enhancement of anti-viral activity. The Chitosan derivatives constructively interact with viral S protein. N-Carboxy methyl Chitosan (NCMC) among the Chitosan derivatives displayed efficient binding affinity. NCMC, when compared to mHTCC, a monomeric Chitosan for its interaction with the S protein, RBD site and ACE2 receptor, displayed efficient binding affinity with binding energy of -7.9, -6.3 and -7.4; -6.2, -4.8 and -5.5 Kcal/mol respectively. The interaction of S protein with ACE2 and ligand mHTCC-S protein complex and NCMC-S protein complex with ACE2 was calculated through flexible docking resulted in efficient reduction of binding energy from -901.2kJ/mol to -765.06kJ/mol and-814.72kJ/mol respectively, elucidated that the binding affinity of the viral S protein for its receptor ACE2 decreases in the presence of NCMC/mHTCC. The computational study envisages the antiviral efficiency of NCMC, mHTCC and biocompatible Chitosan derivatives for the first time,as preventive intervention against Covid-19.

Keywords

Chitosan; mHTCC; SARS-CoV-2; S protein; ACE2; Molecular interaction

Subject

Biology and Life Sciences, Virology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.